Soren Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026
Rhea-AI Summary
Soren Acquisition Corp (Nasdaq: SORN) announced that, effective February 27, 2026, holders of units may elect to separately trade Class A ordinary shares and warrants included in the Units.
The Class A Ordinary Shares will trade as SORN, the whole warrants as SORNW, and unsplit Units will continue trading as SORNU. Each Unit contains one Class A Ordinary Share and one-third of a warrant; each whole warrant is exercisable for one share at $11.50. No fractional warrants will be issued. BTIG acted as sole book-running manager.
Positive
- Separation effective Feb 27, 2026 enables distinct share and warrant liquidity
- Warrants exercisable at $11.50 per share, providing clear conversion economics
Negative
- Only whole SORNW warrants will trade; fractional warrants are not issued, limiting partial-unit liquidity
- Potential dilution if warrants are exercised at $11.50, increasing shares outstanding
Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (Nasdaq: SORNU) (the “Company”) announced today that, commencing February 27, 2026, the holders of the units issued in the Company’s initial public offering (the “Units”), each consisting of one Class A ordinary share of the Company, par value
BTIG, LLC acted as sole book-running manager for the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Soren Acquisition Corp.
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.
The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as advisors to the Company.
FORWARD-LOOKING STATEMENTS
This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Company Contact
Soren Acquisition Corp.
Arghavan Di Rezze, Chief Executive Officer
apd@direzzefamilyoffice.com